Johnson Matthey PLC (LON:JMAT – Get Free Report) insider Alastair Judge purchased 12 shares of Johnson Matthey stock in a transaction dated Wednesday, August 12th. The shares were bought at an average price of GBX 2,193 per share, with a total value of £263.16.
Alastair Judge also recently made the following trade(s):
- On Friday, July 10th, Alastair Judge bought 12 shares of Johnson Matthey stock. The shares were acquired at an average price of GBX 1,909 per share, for a total transaction of £229.08.
- On Wednesday, June 10th, Alastair Judge purchased 14 shares of Johnson Matthey stock. The stock was bought at an average price of GBX 1,990 per share, with a total value of £278.60.
Johnson Matthey Stock Performance
Johnson Matthey stock traded down GBX 22 during mid-day trading on Thursday, reaching GBX 2,190. 417,565 shares of the stock traded hands, compared to its average volume of 2,430,549. Johnson Matthey PLC has a 12-month low of GBX 1,731.83 and a 12-month high of GBX 2,434. The stock has a market capitalization of £3.68 billion, a PE ratio of -38.29, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.94. The company has a debt-to-equity ratio of 69.69, a current ratio of 1.56 and a quick ratio of 0.76. The business’s 50-day moving average is GBX 2,015.71 and its 200-day moving average is GBX 2,063.89.
Analysts Set New Price Targets
Several equities research analysts have recently issued reports on the stock. Berenberg Bank lifted their price objective on shares of Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the company a “buy” rating in a research report on Monday, June 1st. Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 2,330 price target on shares of Johnson Matthey in a research note on Tuesday, August 4th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a GBX 2,400 price objective on shares of Johnson Matthey in a research report on Monday, July 6th. Finally, UBS Group reaffirmed a “neutral” rating and set a GBX 2,200 price target on shares of Johnson Matthey in a research note on Friday, May 22nd. Four research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of GBX 2,283.33.
View Our Latest Research Report on Johnson Matthey
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Featured Articles
- Five stocks we like better than Johnson Matthey
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
- Lumentum Just Delivered the AI Growth Investors Wanted
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
